Kangmei Pharmaceutical Market Cap

Kangmei Pharmaceutical has a market cap or net worth of 21.02 billion as of May 21, 2026. Its market cap has decreased by -24.94% in one year.

Market Cap

21.02B

Enterprise Value

20.00B

Revenue

5.03B

Ranking

n/a

PE Ratio

n/a

Stock Price

1.52

Market Cap Chart

Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 21.02B, an increase of 715.19%. That is a compound annual growth rate of 8.69%.

Market Cap History

Date	Market Cap	% Change
May 20, 2026	21.71B	-17.80%
Dec 31, 2025	26.41B	-18.58%
Dec 31, 2024	32.44B	25.81%
Dec 29, 2023	25.79B	-15.45%
Dec 30, 2022	30.50B	-28.80%
Dec 31, 2021	42.84B	221.38%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Dizal (Jiangsu) Pharmaceutical	24.19B
Walvax Biotechnology	22.69B
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	22.29B
Tasly Pharmaceutical Group	21.56B
Hybio Pharmaceutical	21.13B
Jiangsu Nhwa Pharmaceutical Co., LTD	21.07B
Jilin Aodong Pharmaceutical Group	20.94B
Betta Pharmaceuticals	20.49B

Market Cap Rankings